Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Markets
Stocks
F&O
Mutual Funds
ETFs
More
Research
Pricing
Resources

Sector: Pharmaceuticals & Biotechnology

Mid Cap

Syngene Intl Share Price

Syngene International Ltd.

₹394.50

-4.55(-1.14%)

Invest in SYNGENE with up to 4.00x margin.

Trade with MTF

9th Apr 2026 | 3:28 PM

NSE : SYNGENE

Open Free Demat Account

Syngene Intl Performance

Price Movement

₹394.50

₹390.25

₹405.40

↘ Today's Low↗ Today's High

1 Year Performance

₹394.50

₹380.00

₹754.85

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹405.40

Low₹390.25

Open at₹402.40

Prev Close₹399.05

Volumes9.36 L

Avg Price₹397.21

Lower Circuit₹319.25

Upper Circuit₹478.85

Historical Performance

3M High₹636.35

3M Low₹380.00

1 Yr High₹754.85

1 Yr Low₹380.00

3 Yr High₹960.60

3 Yr Low₹380.00

5 Yr High₹960.60

5 Yr Low₹380.00

Syngene Intl Fundamentals

Market Cap

High in industry

15,839.50 Cr.

PE Ratio (TTM)

High in industry

Dividend Yield

Below industry Median

0.30

Net Profit TTM

30% decr over last year

352.10

Net Profit Growth

30% decr over last year

352.10

PEG Ratio

Negative PEG TTM

-1.50

ROE

12% decr over last year

10.49

Operating Revenue TTM

3,720.20

Operating Revenue Growth

5.1% incr over last year

Book Value

Above industry Median

3.30

MFI

MFI is mid-range

68.81

RSI

RSI is mid-range

43.05

EPS (TTM)

12.35

Debt to Equity

0.03

Face Value

Operating Profit Margin Qtr.

28.05

Operating Profit Qtr.

209.20

Net Profit Qtr.

Operating Revenue Qtr.

917.10

PB Ratio

3.30

Syngene Intl Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	834.40	830.10	799.30	948.40	877.10
Operating Expense	649.70	652.60	631.20	638.40	626.30
Operating Profit	184.70	177.50	168.10	310	250.80
Depreciation	97.10	100.10	94.60	89.60	92.30
Interest	6.20	7.40	5.90	10.10	6.70
Tax	13.60	18	10.20	54.30	46.70
Net Profit	16.50	66.20	74	174.40	123.10

Syngene Intl Technicals

Syngene International Ltd. EMA & SMA

₹394.50

-4.55 (-1.14%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹397

Day EMA10 ₹399.9

Day EMA12 ₹401.1

Day EMA20 ₹407.1

Day EMA26 ₹413.5

Day EMA50 ₹447

Day EMA100 ₹505.1

Day EMA200 ₹571.3

Syngene Intl Support and Resistance

Resistance

First Resistance₹402.42

Second Resistance₹405.78

Third Resistance₹409.17

Support

First Support₹395.67

Second Support₹392.28

Third Support₹388.92

Technical Indicators

Day RSI43.05

Day MFI68.81

Day ADX22.81

Day Commodity Channel Index-49.40

William-58.90

Day MACD-12.44

Day MACD Signal Line-14.36

Day ATR15.86

Day ROC125-37.21

Day ROC21-1.15

Syngene Intl Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	54.7	52.7	52.7	52.7	52.7	52.7
FII	20.7	20.6	19.5	16.5	16.3	15
DII	17.5	19.6	21.5	24.1	24.6	25.8
Public	6.7	6.8	6	6.4	6.1	6.2

Syngene Intl Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	18.22 L	23.45 L	77.67%
Week	12.5 L	17.23 L	72.55%
1 Month	9.67 L	20.14 L	47.99%
6 Month	5.67 L	11.1 L	51.02%

Syngene Intl SWOT Analysis

Strengths13

Weakness17

Opportunity4

Threats0

Benjamin Graham Value Screen

Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV

Relative Outperformance versus Industry over 1 Month

PEG lower than Industry PEG

Good Aggregate Candlestick Strength (total bullish - bearish candlesticks)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Companies with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Syngene Intl Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
27 Jun, 2025	1.25	FINAL	27 Jun, 2025	Equity Share
28 Jun, 2024	1.25	FINAL	28 Jun, 2024	Equity Share
30 Jun, 2023	0.5	FINAL	30 Jun, 2023	Equity Share
30 Jun, 2022	0.5	FINAL	01 Jul, 2022	Equity Share
30 Jun, 2022	0.5	SPECIAL	01 Jul, 2022	Equity Share
16 Jul, 2019	0.5	FINAL	17 Jul, 2019	Equity Share
17 Jul, 2018	1	FINAL	18 Jul, 2018	Equity Share
20 Jul, 2017	1	FINAL	21 Jul, 2017	Equity Share
17 Mar, 2016	1	INTERIM	19 Mar, 2016	Equity Share

Syngene Intl Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Rubicon Research Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.	Akums Drugs & Pharmaceuticals Ltd.
Price (₹)	₹1,565	₹613.90	₹864	₹1,370	₹4,550	₹492.20
% Change	0.66%	-0.35%	8.20%	1.97%	1.57%	-2.52%
Revenue TTM (₹ Cr)	-	-	₹1,598.19	₹1,419.33	₹878.40	₹4,256.70
Net Profit TTM (₹ Cr)	-	-	₹206.20	₹20.10	₹240.10	₹318.19
PE TTM	-	-	68.60	784.40	43.80	24.30
1 Year Return	47.07	3.42	76.54	-11.44	-6.21	10.23
ROCE	30.24	34.78	34.76	3.26	-	11.27

Similar Stocks

BLUEJET

Blue Jet Healthcare Ltd

₹ 370.00

-1.20%

CONCORDBIO

Concord Biotech Ltd.

₹ 1059.00

+0.88%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 679.00

-1.34%

PPLPHARMA

Piramal Pharma Ltd.

₹ 143.50

-0.19%

SUPRIYA

Supriya Lifescience Ltd.

₹ 626.70

-1.61%

ACUTAAS

Acutaas Chemicals Ltd.

₹ 2339.80

+0.17%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1040.55

-0.35%

COHANCE

Cohance Lifesciences Ltd.

₹ 320.00

+3.39%

ERIS

Eris Lifesciences Ltd.

₹ 1364.00

+1.04%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 720.00

-0.86%

STAR

Strides Pharma Science Ltd.

₹ 995.00

+3.17%

GRANULES

Granules India Ltd.

₹ 634.20

-1.57%

FDC

FDC Ltd.

₹ 341.50

-1.26%

SHILPAMED

Shilpa Medicare Ltd.

₹ 418.65

+3.70%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 871.85

-0.67%

NATCOPHARM

Natco Pharma Ltd.

₹ 1127.00

+1.31%

CAPLIPOINT

Caplin Point Laboratories Ltd.

₹ 1659.90

-0.02%

NEULANDLAB

Neuland Laboratories Ltd.

₹ 14726.00

+4.77%

MARKSANS

Marksans Pharma Ltd.

₹ 174.90

+0.17%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 8050.00

+2.03%

SANOFI

Sanofi India Ltd.

₹ 3450.00

+0.89%

PGHL

Procter & Gamble Health Ltd.

₹ 4800.00

-0.90%

JSLL

Jeena Sikho Lifecare Ltd.

₹ 650.70

-0.75%

FAQ's on SYNGENE

What is the current share price of Syngene International Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Syngene International Ltd. is ₹ 394.5 on the NSE and ₹ 394.9 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Syngene International Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Syngene International Ltd. is approximately ₹ 15839.5 Cr.

What are the PE and PB ratios for Syngene International Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Syngene International Ltd. is 45, and the Price-to-Book (PB) ratio is 3.3.

What is the 52-Week High and Low for Syngene International Ltd.?

Over the past 52 weeks, the highest price reached by Syngene International Ltd. shares was ₹ 754.85, and the lowest price was ₹ 380.

What is the current dividend yield for Syngene International Ltd.?

As of 6 June 2025, the dividend yield for Syngene International Ltd. is 0.3%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Syngene International Ltd.?

Significant shareholdings in Syngene International Ltd. typically include entities such as:

Promoter
Mutual Funds
FII
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Syngene International Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Syngene International Ltd. is often compared with other major players such as Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs and Corona Remedies for analysis and benchmarking.

What is the latest dividend information for Syngene International Ltd.?

Syngene International Ltd. last declared a FINAL dividend of ₹ 1.25 per share for the financial period ending 2025. The record date was set as 2025-06-27, and the payment was/is scheduled around 2025-06-27. For the most current dividend announcements, refer to official company filings.